Yamazaki N, Kiyohara Y, Uhara H, Tsuchida T, et al. Postmarketing surveillance of nivolumab plus ipilimumab combination therapy in Japanese patients with unresectable malignant melanoma. J Dermatol 2023 Jun 22. doi: 10.1111/1346-8138.16820.
PMID: 37350027